Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Baixin Ye"'
Autor:
Yingze Ye, Tong Jin, Xu Zhang, Zhi Zeng, Baixin Ye, Jinchen Wang, Yi Zhong, Xiaoxing Xiong, Lijuan Gu
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 13 (2019)
Ischemic stroke is a devastating disease with long-term disability. However, the pathogenesis is unclear and treatments are limited. Meisoindigo, a second-generation derivative of indirubin, has general water solubility and is well-tolerated. Previou
Externí odkaz:
https://doaj.org/article/c0c0285759e64e99840628d25c21be5b
Publikováno v:
Molecular Cancer, Vol 17, Iss 1, Pp 1-16 (2018)
Abstract Intratumor heterogeneity of tumor clones and an immunosuppressive microenvironment in cancer ecosystems contribute to inherent difficulties for tumor treatment. Recently, chimeric antigen receptor (CAR) T-cell therapy has been successfully a
Externí odkaz:
https://doaj.org/article/106ea07dc8374122939742c4c4b6d020
Autor:
Baixin Ye, Xiaoxing Xiong, Xu Deng, Lijuan Gu, Qiongyu Wang, Zhi Zeng, Xiang Gao, Qingping Gao, Yueying Wang
Publikováno v:
Pharmaceutical Biology, Vol 55, Iss 1, Pp 673-679 (2017)
Context: Inflammatory disease is a big threat to human health. Leukocyte chemotactic migration is required for efficient inflammatory response. Inhibition of leukocyte chemotactic migration to the inflammatory site has been shown to provide therapeut
Externí odkaz:
https://doaj.org/article/e18e081944354689a0c118b32c02c270
Autor:
Baixin Ye, Creed M. Stary, Qingping Gao, Qiongyu Wang, Zhi Zeng, Zhihong Jian, Lijuan Gu, Xiaoxing Xiong
Publikováno v:
Journal of Immunology Research, Vol 2017 (2017)
A significant proportion of hematological malignancies remain limited in treatment options. Immune system modulation serves as a promising therapeutic approach to eliminate malignant cells. Cytotoxic T lymphocytes (CTLs) play a central role in antitu
Externí odkaz:
https://doaj.org/article/04171078da1348aa908da4bbba2b8c36
Publikováno v:
Analytical Cellular Pathology, Vol 2016 (2016)
Cellular heterogeneity is a fundamental characteristic of many cancers. A lack of cellular homogeneity contributes to difficulty in designing targeted oncological therapies. Therefore, the development of novel methods to determine and characterize on
Externí odkaz:
https://doaj.org/article/93c8e4cfbb9f4b008dff46d3279ce120
Publikováno v:
Zhejiang Da Xue Xue Bao Yi Xue Ban
Chimeric antigen receptor (CAR) T cell therapy has shown significant efficacy for hematological malignancies, however, it needs to be further optimized. Recently, the lipid nanoparticle (LNP)-mRNA delivery system as a nonviral gene transfer vector ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c886d49fba34d19653eb485e52c8ee
https://pubmed.ncbi.nlm.nih.gov/36161298
https://pubmed.ncbi.nlm.nih.gov/36161298
Publikováno v:
Cancer Letters. 538:215691
Clonal hematopoiesis (CH) is a clonal expansion of single hematopoietic stem cells (HSC) with germline or somatic mutations accumulated in specific genes, which usually leads to clonal dominance via multiple biological pathways and increases the risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01e49f12051ddf30c0a879ee9fc4bf5d
https://doi.org/10.1016/j.canlet.2022.215691
https://doi.org/10.1016/j.canlet.2022.215691
Publikováno v:
Cancer Letters. 416:42-56
The diagnostic, monitoring and therapeutic options for cancers currently remain limited. These limitations represent a large threat to human health. Adaptive immunity, which is dependent on diverse repertoires of B cell receptors (BCRs) and T cell re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::811e7eedab109f9aa4f1a400d7706ee9
https://doi.org/10.1016/j.canlet.2017.12.017
https://doi.org/10.1016/j.canlet.2017.12.017
Publikováno v:
Molecular Cancer, Vol 17, Iss 1, Pp 1-16 (2018)
Molecular Cancer
Molecular Cancer
Intratumor heterogeneity of tumor clones and an immunosuppressive microenvironment in cancer ecosystems contribute to inherent difficulties for tumor treatment. Recently, chimeric antigen receptor (CAR) T-cell therapy has been successfully applied in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5b0ddebc2cb99f0bf1f51bc1f97c792
http://link.springer.com/article/10.1186/s12943-018-0814-0
http://link.springer.com/article/10.1186/s12943-018-0814-0
Autor:
Qiongyu Wang, Baixin Ye, Zhi Zeng, Yueying Wang, Lijuan Gu, Xiang Gao, Xiaoxing Xiong, Qingping Gao, Xu Deng
Publikováno v:
Pharmaceutical Biology, Vol 55, Iss 1, Pp 673-679 (2017)
Context: Inflammatory disease is a big threat to human health. Leukocyte chemotactic migration is required for efficient inflammatory response. Inhibition of leukocyte chemotactic migration to the inflammatory site has been shown to provide therapeut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6672e35fecad69e54b93f5e847aa9679
https://doi.org/10.1080/13880209.2016.1238949
https://doi.org/10.1080/13880209.2016.1238949